(From The Washington Post) Several universities halted vaccine distribution efforts Tuesday after federal health officials announced they would review “extremely rare” cases of potentially dangerous blood clots in recipients of the Johnson & Johnson vaccine. In some cases, like at the University of Virginia, officials said they will lean on existing supplies of the Pfizer-BioNTech and Moderna vaccines. Many campuses counted on the one-dose vaccine to inoculate students before summer — which begins at some schools in early May.
More from The Washington Post
All news on NetAssets.org
Sign in to leave a comment
Get Net Assets NOW
NBOA's free twice-monthly newsletter
1400 I Street, NW, Suite 675Washington, DC 20005www.nboa.org